Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Faizan K. Mohsin"'
Autor:
Miran Kenk, Thenappan Chandrasekar, Christopher J.D. Wallis, Shabbir M.H. Alibhai, Hanan Goldberg, Girish S. Kulkarni, Linda Z. Penn, Olli Saarela, Zachary Klaassen, Alejandro Berlin, Faizan K. Mohsin, Refik Saskin, Neil Fleshner
Publikováno v:
Prostate Cancer and Prostatic Diseases. 23:622-629
Proton pump inhibitors (PPIs) are commonly prescribed medications that have been shown to have contradicting effects on cancer. We aimed to investigate the effect of pantoprazole and other PPIs on prostate cancer (PCa) specific mortality (PCSM), use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7a5dbfe007dd8111d14ab4b1abce43b
https://doi.org/10.1038/s41391-020-0248-9
https://doi.org/10.1038/s41391-020-0248-9
Autor:
Hanan Goldberg, Faizan K. Mohsin, Thenappan Chandrasekar, Christopher J.D. Wallis, Zachary Klaassen, Ardalan E. Ahmad, Refik Saskin, Miran Kenk, Olli Saarela, Girish S. Kulkarni, Shabbir M.H. Alibhai, Neil Fleshner
Publikováno v:
Can Urol Assoc J
Introduction: This was a secondary analysis aiming to assess whether hydrophilic or hydrophobic statins have a differential effect on urinary retention (UR) and lower urinary tract symptoms (LUTS) in men following a prostate biopsy (PB), who were at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702ec88c8136a34fe9ebea07186779b8
https://pubmed.ncbi.nlm.nih.gov/34941486
https://pubmed.ncbi.nlm.nih.gov/34941486
Autor:
Olli Saarela, Alejandro Berlin, Zachary Klaassen, Girish S. Kulkarni, Christopher J.D. Wallis, Refik Saskin, Neil Fleshner, Shabbir M.H. Alibhai, Thenappan Chandrasekar, Hanan Goldberg, Faizan K. Mohsin, Ardalan E. Ahmad, Miran Kenk
Publikováno v:
Urologic oncology. 39(3)
Purpose Metformin, an insulin sensitizer, is the most common first-line antidiabetic therapy. There is increasing evidence suggesting metformin can prevent the emergence of prostate cancer (CaP). We aimed to analyze the chemopreventive role of metfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6b9f2c46ec6817f5ac36d7285829615
https://pubmed.ncbi.nlm.nih.gov/32951988
https://pubmed.ncbi.nlm.nih.gov/32951988
Autor:
Shabbir M.H. Alibhai, Christopher J.D. Wallis, Thenappan Chandrasekar, Hanan Goldberg, Refik Saskin, Rashid K. Sayyid, Zachary Klaassen, Neil Fleshner, Olli Saarela, Linda Z. Penn, Ardalan E. Ahmad, Miran Kenk, Girish S. Kulkarni, Faizan K. Mohsin, Alejandro Berlin
Publikováno v:
European urology focus. 7(3)
Background The chemopreventive effect of various medications in prostate cancer (PCa) has gained interest. Specifically, the potential impact of statins on PCa incidence has been studied, but solely as a “drug family” overlooking the distinctive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55256513a10ff70d5f2fd6f06ab1b4f
https://pubmed.ncbi.nlm.nih.gov/32620539
https://pubmed.ncbi.nlm.nih.gov/32620539
Autor:
Hanan, Goldberg, Faizan K, Mohsin, Refik, Saskin, Girish S, Kulkarni, Alejandro, Berlin, Miran, Kenk, Christopher J D, Wallis, Thenappan, Chandrasekar, Zachary, Klaassen, Olli, Saarela, Linda, Penn, Shabbir M H, Alibhai, Neil, Fleshner
Publikováno v:
Prostate cancer and prostatic diseases. 23(4)
Proton pump inhibitors (PPIs) are commonly prescribed medications that have been shown to have contradicting effects on cancer. We aimed to investigate the effect of pantoprazole and other PPIs on prostate cancer (PCa) specific mortality (PCSM), use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a72563e6878c1a696b0d8f05bc9e9d07
https://pubmed.ncbi.nlm.nih.gov/32641738
https://pubmed.ncbi.nlm.nih.gov/32641738
Autor:
Thenappan Chandrasekar, Hanan Goldberg, Jaime Omar Herrera Cáceres, Shabbir M.H. Alibhai, Robert J. Hamilton, Christopher J.D. Wallis, Neil Fleshner, Alejandro Berlin, Girish S. Kulkarni, Ardalan Ahmed, Zachary Klaassen, Faizan K. Mohsin, Refik Saskin, Dixon T.S. Woon
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Prostate cancer (PC) is the most common non-cutaneous cancer in Canadian men and the third most common cause of cancer death in males accounting for 10% of all male canc...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6213c2a63118a9d348812d0155a0e9da
https://doi.org/10.1097/01.ju.0000555449.91087.2b
https://doi.org/10.1097/01.ju.0000555449.91087.2b